2-METHOXYACETOPHENONE
2-METHOXYACETOPHENONE structure
|
Common Name | 2-METHOXYACETOPHENONE | ||
|---|---|---|---|---|
| CAS Number | 4079-52-1 | Molecular Weight | 150.174 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 237.9±0.0 °C at 760 mmHg | |
| Molecular Formula | C9H10O2 | Melting Point | 7-8 °C(lit.) | |
| MSDS | USA | Flash Point | 101.7±0.0 °C | |
| Name | 2-methoxyacetophenone |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 237.9±0.0 °C at 760 mmHg |
| Melting Point | 7-8 °C(lit.) |
| Molecular Formula | C9H10O2 |
| Molecular Weight | 150.174 |
| Flash Point | 101.7±0.0 °C |
| Exact Mass | 150.068085 |
| PSA | 26.30000 |
| LogP | 1.40 |
| Vapour Pressure | 0.0±0.4 mmHg at 25°C |
| Index of Refraction | 1.505 |
| Personal Protective Equipment | Eyeshields;Gloves |
|---|---|
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2914509090 |
| HS Code | 2914509090 |
|---|---|
| Summary | HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
|
Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Drug Des. Devel. Ther. 9 , 349-417, (2015) Plumbagin (PLB) has exhibited a potent anticancer effect in preclinical studies, but the molecular interactome remains elusive. This study aimed to compare the quantitative proteomic responses to PLB ... |
|
|
Pharmacokinetics and pharmacodynamics of ticagrelor and prasugrel in healthy male Korean volunteers.
Clin. Ther. 37(3) , 563-73, (2015) A combination of clopidogrel and aspirin is the standard treatment for patients with acute coronary syndrome and those undergoing percutaneous coronary intervention. Two novel antiplatelet agents, tic... |
|
|
Carboxylesterase 1-mediated drug-drug interactions between clopidogrel and simvastatin.
Biol. Pharm. Bull. 38(2) , 292-7, (2015) Patients with coronary artery disease often receive concurrent treatment with clopidogrel and a hydroxymethylglutaryl (HMG)-CoA reductase inhibitor medication. Accordingly, potential drug-drug interac... |
| Ethanone,2-methoxy-1-phenyl |
| Acetophenone,2-methoxy |
| 2-Methoxyacetophenone |
| 1-phenyl-3-methoxyethan-1-one |
| methoxybenzoyl-methane |
| 2-methoxy-1-phenylethan-1-one |
| 2-methyl-1-phenylethanone |
| EINECS 223-802-4 |
| α-Methoxyacetophenone |
| methoxyacetophenone |
| Ethanone, 2-methoxy-1-phenyl- |
| MFCD00008499 |
| 2-Methoxy-1-phenylethanone |